IndraLab
Statements
Lisinopril inhibits ACE2. 10 / 10
|
2
8
reach
"One theory posits that binding of ACE-2 receptors by SARS coronaviruses in pulmonary vascular endothelium leads to downregulation of these receptors and abrogation of normal vasoregulation in these regions.42 Indeed, ACE-2 inhibition by lisinopril has previously been shown to attenuate hypoxic pulmonary vasoconstriction.43 Although this theory is intriguing, the renin-angiotensin-aldosterone system remains a minor contributor to pulmonary vasoregulation in comparison to the release of local mediators (endothelin, prostacyclin, and nitric oxide), which could be affected by direct viral injury to pulmonary artery endothelial cells."